Elevance Health Inc.
03/10/2026 | Press release | Distributed by Public on 03/10/2026 04:04
Regulation FD Disclosure (Form 8-K)
Item 7.01 - Regulation FD Disclosure
Officers of Elevance Health, Inc. (the "Company") expect to speak with investors and analysts over the next week. During these meetings, Company officers will reaffirm adjusted shareholders' earnings for full year 2026 to be at least $25.50 per diluted share. The Company also will reaffirm its 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.
As reported in a Current Report on Form 8-K filed by the Company on March 2, 2026, the Company was notified by the Centers for Medicare & Medicaid Services ("CMS") on February 27, 2026 of its intent to impose intermediate sanctions suspending enrollment of Medicare beneficiaries into the Company's Medicare Advantage-Prescription Drug plans and suspending certain communication activities to Medicare beneficiaries effective as of March 31, 2026 (the "Sanctions"), unless CMS determines the issues identified have been satisfactorily addressed.
The Company's adjusted shareholders' earnings and benefit expense ratio guidance set forth above includes the impact of the Sanctions, if imposed. At this time, the Company is unable to provide a reconciliation of its guidance for adjusted shareholders' earnings per diluted share for full year 2026 to shareholders' earnings per diluted share for full year 2026, the most directly comparable GAAP financial measure, without unreasonable effort because the Company cannot reasonably estimate the impact of any potential financial payments to resolve this matter on its GAAP shareholders' earnings per diluted share for full year 2026.
Elevance Health Inc. published this content on March 10, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 10, 2026 at 10:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]